{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T07:50:00Z","timestamp":1782460200271,"version":"3.54.5"},"reference-count":71,"publisher":"Japanese Circulation Society","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ J"],"published-print":{"date-parts":[[2021,8,25]]},"DOI":"10.1253\/circj.cj-21-0077","type":"journal-article","created":{"date-parts":[[2021,5,19]],"date-time":"2021-05-19T22:11:55Z","timestamp":1621462315000},"page":"1469-1478","source":"Crossref","is-referenced-by-count":17,"title":["Genetic Determinants and Genotype-Phenotype Correlations in Vietnamese Patients With Dilated Cardiomyopathy"],"prefix":"10.1253","volume":"85","author":[{"given":"Thuy Vy","family":"Nguyen","sequence":"first","affiliation":[{"name":"Department of Genetics, Faculty of Biology and Biotechnology, University of Science, VNUHCM [Vietnam National University, Ho Chi Minh City]"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minh Thu","family":"Tran Vu","sequence":"additional","affiliation":[{"name":"Tam Duc Heart Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thi Nam Phuong","family":"Do","sequence":"additional","affiliation":[{"name":"Heart Institute of Ho Chi Minh City"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thi Huynh Nga","family":"Tran","sequence":"additional","affiliation":[{"name":"Heart Institute of Ho Chi Minh City"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thi Hao","family":"Do","sequence":"additional","affiliation":[{"name":"Heart Institute of Ho Chi Minh City"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thi My Hanh","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Heart Institute of Ho Chi Minh City"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bao Nam","family":"Tran Huynh","sequence":"additional","affiliation":[{"name":"KTEST Science Company"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan Anh","family":"Le","sequence":"additional","affiliation":[{"name":"KTEST Science Company"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ngoc Thieu","family":"Nguyen Pham","sequence":"additional","affiliation":[{"name":"KTEST Science Company"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thi Dieu Ai","family":"Nguyen","sequence":"additional","affiliation":[{"name":"KTEST Science Company"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thi My Nuong","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Department of Genetics, Faculty of Biology and Biotechnology, University of Science, VNUHCM [Vietnam National University, Ho Chi Minh City]"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ngoc Hong Phuong","family":"Le","sequence":"additional","affiliation":[{"name":"Research Center for Genetics and Reproductive Health, School of Medicine, VNUHCM [Vietnam National University, Ho Chi Minh City]"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinh","family":"Pham Nguyen","sequence":"additional","affiliation":[{"name":"Tam Duc Heart Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thuy Duong","family":"Ho Huynh","sequence":"additional","affiliation":[{"name":"Department of Genetics, Faculty of Biology and Biotechnology, University of Science, VNUHCM [Vietnam National University, Ho Chi Minh City]"},{"name":"Research Center for Genetics and Reproductive Health, School of Medicine, VNUHCM [Vietnam National University, Ho Chi Minh City]"},{"name":"KTEST Science Company"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Pinto YM, Elliott PM, Arbustini E, Adler Y, Anastasakis A, B\u00f6hm M, et al. Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice: A position statement of the ESC working group on myocardial and pericardial diseases. <i>Eur Heart J<\/i> 2016; 37: 1850\u20131858.","DOI":"10.1093\/eurheartj\/ehv727"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Hershberger RE, Hedges DJ, Morales A. Dilated cardiomyopathy: The complexity of a diverse genetic architecture. <i>Nat Rev Cardiol<\/i> 2013; 10: 531\u2013547.","DOI":"10.1038\/nrcardio.2013.105"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Mestroni L, Brun F, Spezzacatene A, Sinagra G, Taylor MRG. Genetic causes of dilated cardiomyopathy. <i>Prog Pediatr Cardiol<\/i> 2014; 37: 13\u201318.","DOI":"10.1016\/j.ppedcard.2014.10.003"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Japp AG, Gulati A, Cook SA, Cowie MR, Prasad SK. The diagnosis and evaluation of dilated cardiomyopathy. <i>J Am Coll Cardiol<\/i> 2016; 67: 2996\u20133010.","DOI":"10.1016\/j.jacc.2016.03.590"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Charron P, Arad M, Arbustini E, Basso C, Bilinska Z, Elliott P, et al. Genetic counselling and testing in cardiomyopathies: A position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. <i>Eur Heart J<\/i> 2010; 31: 2715\u20132728.","DOI":"10.1093\/eurheartj\/ehq271"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Li H, Durbin R. Fast and accurate long-read alignment with Burrows-Wheeler transform. <i>Bioinformatics<\/i> 2010; 26: 589\u2013595.","DOI":"10.1093\/bioinformatics\/btp698"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Van der Auwera GA, Carneiro MO, Hartl C, Poplin R, del Angel G, Levy-Moonshine A, et al. From FastQ data to high-confidence variant calls: The genome analysis toolkit best practices pipeline. <i>Curr Protoc Bioinformatics<\/i> 2013; 43: 11.10.1\u201311.10.33.","DOI":"10.1002\/0471250953.bi1110s43"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Wang K, Li M, Hakonarson H. ANNOVAR: Functional annotation of genetic variants from high-throughput sequencing data. <i>Nucleic Acids Res<\/i> 2010; 38: e164.","DOI":"10.1093\/nar\/gkq603"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. <i>Genet Med<\/i> 2015; 17: 405\u2013423.","DOI":"10.1038\/gim.2015.30"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Whiffin N, Minikel E, Walsh R, O\u2019Donnell-Luria AH, Karczewski K, Ing AY, et al. Using high-resolution variant frequencies to empower clinical genome interpretation. <i>Genet Med<\/i> 2017; 19: 1151\u20131158.","DOI":"10.1038\/gim.2017.26"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Auton A, Abecasis GR, Altshuler DM, Durbin RM, Bentley DR, Chakravarti A, et al. A global reference for human genetic variation. <i>Nature<\/i> 2015; 526: 68\u201374.","DOI":"10.1038\/nature15393"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Whiffin N, Walsh R, Govind R, Edwards M, Ahmad M, Zhang X, et al. CardioClassifier: Disease- and gene-specific computational decision support for clinical genome interpretation. <i>Genet Med<\/i> 2018; 20: 1246\u20131254.","DOI":"10.1038\/gim.2017.258"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Liu X, Wu C, Li C, Boerwinkle E. dbNSFP v3.0: A one-stop database of functional predictions and annotations for human nonsynonymous and splice-site SNVs. <i>Hum Mutat<\/i> 2016; 37: 235\u2013241.","DOI":"10.1002\/humu.22932"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Tian Y, Pesaran T, Chamberlin A, Fenwick RB, Li S, Gau CL, et al. REVEL and BayesDel outperform other in silico meta-predictors for clinical variant classification. <i>Sci Rep<\/i> 2019; 9: 1\u20136.","DOI":"10.1038\/s41598-019-49224-8"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Houdayer C. In silico prediction of splice-affecting nucleotide variants. <i>Methods Mol Biol<\/i> 2011; 760: 269\u2013281.","DOI":"10.1007\/978-1-61779-176-5_17"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Davydov EV, Goode DL, Sirota M, Cooper GM, Sidow A, Batzoglou S. Identifying a high fraction of the human genome to be under selective constraint using GERP++. <i>PLoS Comput Biol<\/i> 2010; 6: e1001025.","DOI":"10.1371\/journal.pcbi.1001025"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Morales A, Kinnamon DD, Jordan E, Platt J, Vatta M, Dorschner MO, et al. Variant interpretation for dilated cardiomyopathy: Refinement of the Americal College of Medical Genetics and Genomics\/ClinGen Guidelines for the DCM Precision Medicine Study. <i>Circ Genomic Precis Med<\/i> 2020; 13: e002480.","DOI":"10.1161\/CIRCGEN.119.002480"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Mazzarotto F, Tayal U, Buchan RJ, Midwinter W, Wilk A, Whiffin N, et al. Reevaluating the genetic contribution of monogenic dilated cardiomyopathy. <i>Circulation<\/i> 2020; 141: 387\u2013398.","DOI":"10.1161\/CIRCULATIONAHA.119.037661"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Verdonschot JAJ, Hazebroek MR, Krapels IPC, Henkens MTHM, Raafs A, Wang P, et al. Implications of genetic testing in dilated cardiomyopathy. <i>Circ Genomic Precis Med<\/i> 2020; 13: 476\u2013487.","DOI":"10.1161\/CIRCGEN.120.003031"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Zhang XL, Xie J, Lan RF, Kang LN, Wang L, Xu W, et al. Genetic basis and genotype-phenotype correlations in Han Chinese patients with idiopathic dilated cardiomyopathy. <i>Sci Rep<\/i> 2020; 10: 2226.","DOI":"10.1038\/s41598-020-58984-7"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Kelly M, Semsarian C. Multiple mutations in genetic cardiovascular disease: A marker of disease severity? <i>Circ Cardiovasc Genet<\/i> 2009; 2: 182\u2013190.","DOI":"10.1161\/CIRCGENETICS.108.836478"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Haas J, Frese KS, Peil B, Kloos W, Keller A, Nietsch R, et al. Atlas of the clinical genetics of human dilated cardiomyopathy. <i>Eur Heart J<\/i> 2015; 36: 1123\u20131135.","DOI":"10.1093\/eurheartj\/ehu301"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. McNally EM, Mestroni L. Dilated cardiomyopathy: Genetic determinants and mechanisms. <i>Circ Res<\/i> 2017; 121: 731\u2013748.","DOI":"10.1161\/CIRCRESAHA.116.309396"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Akinrinade O, Ollila L, Vattulainen S, Tallila J, Gentile M, Salmenper\u00e4 P, et al. Genetics and genotype-phenotype correlations in Finnish patients with dilated cardiomyopathy. <i>Eur Heart J<\/i> 2015; 36: 2327\u20132337.","DOI":"10.1093\/eurheartj\/ehv253"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Van Spaendonck-Zwarts KY, Van Rijsingen IAW, Van Den Berg MP, Lekanne Deprez RH, Post JG, Van Mil AM, et al. Genetic analysis in 418 index patients with idiopathic dilated cardiomyopathy: Overview of 10 years\u2019 experience. <i>Eur J Heart Fail<\/i> 2013; 15: 628\u2013636.","DOI":"10.1093\/eurjhf\/hft013"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Rihal CS, Nishimura RA, Hatle LK, Bailey KR, Tajik AJ. Systolic and diastolic dysfunction in patients with clinical diagnosis of dilated cardiomyopathy: Relation to symptoms and prognosis. <i>Circulation<\/i> 1994; 90: 2772\u20132779.","DOI":"10.1161\/01.CIR.90.6.2772"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Merlo M, Caiffa T, Gobbo M, Adamo L, Sinagra G. Reverse remodeling in dilated cardiomyopathy: Insights and future perspectives. <i>IJC Hear Vasc<\/i> 2018; 18: 52\u201357.","DOI":"10.1016\/j.ijcha.2018.02.005"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Khan MA, Yang EY, Zhan Y, Judd RM, Chan W, Nabi F, et al. Association of left atrial volume index and all-cause mortality in patients referred for routine cardiovascular magnetic resonance: A multicenter study. <i>J Cardiovasc Magn Reson<\/i> 2019; 21: 1\u201312.","DOI":"10.1186\/s12968-018-0517-0"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Gulati A, Ismail TF, Jabbour A, Ismail NA, Morarji K, Ali A, et al. Clinical utility and prognostic value of left atrial volume assessment by cardiovascular magnetic resonance in non-ischaemic dilated cardiomyopathy. <i>Eur J Heart Fail<\/i> 2013; 15: 660\u2013670.","DOI":"10.1093\/eurjhf\/hft019"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Venner C, Selton-Suty C, Huttin O, Erpelding ML, Aliot E, Juilli\u00e8re Y. Right ventricular dysfunction in patients with idiopathic dilated cardiomyopathy: Prognostic value and predictive factors. <i>Arch Cardiovasc Dis<\/i> 2016; 109: 231\u2013241.","DOI":"10.1016\/j.acvd.2015.10.006"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Kawata T, Daimon M, Kimura K, Nakao T, Lee SL, Hirokawa M, et al. Echocardiographic assessment of right ventricular function in routine practice: Which parameters are useful to predict one-year outcome in advanced heart failure patients with dilated cardiomyopathy? <i>J Cardiol<\/i> 2017; 70: 316\u2013322.","DOI":"10.1016\/j.jjcc.2017.02.007"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Moretti M, Merlo M, Barbati G, Di Lenarda A, Brun F, Pinamonti B, et al. Prognostic impact of familial screening in dilated cardiomyopathy. <i>Eur J Heart Fail<\/i> 2010; 12: 922\u2013927.","DOI":"10.1093\/eurjhf\/hfq093"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Robertson J, Lindgren M, Schaufelberger M, Adiels M, Bj\u00f6rck L, Lundberg CE, et al. Body mass index in young women and risk of cardiomyopathy: A long-term follow-up study in Sweden. <i>Circulation<\/i> 2020; 141: 520\u2013529.","DOI":"10.1161\/CIRCULATIONAHA.119.044056"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Robertson J, Schaufelberger M, Lindgren M, Adiels M, Schi\u00f6ler L, Tor\u00e9n K, et al. Higher body mass index in adolescence predicts cardiomyopathy risk in midlife: Long-term follow-up among Swedish men. <i>Circulation<\/i> 2019; 140: 117\u2013125.","DOI":"10.1161\/CIRCULATIONAHA.118.039132"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Franaszczyk M, Chmielewski P, Truszkowska G, Stawinski P, Michalak E, Rydzanicz M, et al. Titin truncating variants in dilated cardiomyopathy: Prevalence and genotype-phenotype correlations. <i>PLoS One<\/i> 2017; 12: 1\u201314.","DOI":"10.1371\/journal.pone.0169007"},{"key":"36","unstructured":"36. Vissing CR, Rasmussen TB, Dybro AM, Olesen MS, Pedersen LN, Jensen M, et al. Dilated cardiomyopathy caused by truncating titin variants: Long-term outcomes, arrhythmias, response to treatment and sex differences. <i>J Med Genet<\/i>, doi:10.1136\/jmedgenet2020-107178."},{"key":"37","unstructured":"37. Roberts AM, Ware JS, Herman DS, Schafer S, Baksi J, Bick AG, et al. Integrated allelic, transcriptional, and phenomic dissection of the cardiac effects of titin truncations in health and disease. <i>Sci Transl Med<\/i> 2015; 7: 270ra6."},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Choi SH, Weng LC, Roselli C, Lin H, Haggerty CM, Shoemaker MB, et al. Association between Titin Loss-of-Function variants and early-onset atrial fibrillation. <i>JAMA<\/i> 2018; 320: 2354\u20132364.","DOI":"10.1001\/jama.2018.18179"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Haggerty CM, Damrauer SM, Levin MG, Birtwell D, Carey DJ, Golden AM, et al. Genomics-first evaluation of heart disease associated with Titin-Truncating variants. <i>Circulation<\/i> 2019; 140: 42\u201354.","DOI":"10.1161\/CIR.0000000000000738"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Tayal U, Newsome S, Buchan R, Whiffin N, Halliday B, Lota A, et al. Phenotype and clinical outcomes of Titin cardiomyopathy. <i>J Am Coll Cardiol<\/i> 2017; 70: 2264\u20132274.","DOI":"10.1016\/j.jacc.2017.08.063"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Koene RJ, Adkisson WO, Benditt DG. Syncope and the risk of sudden cardiac death: Evaluation, management, and prevention. <i>J Arrhythmia<\/i> 2017; 33: 533\u2013544.","DOI":"10.1016\/j.joa.2017.07.005"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Tabish AM, Azzimato V, Alexiadis A, Buyandelger B, Kn\u00f6ll R. Genetic epidemiology of titin-truncating variants in the etiology of dilated cardiomyopathy. <i>Biophys Rev<\/i> 2017; 9: 207\u2013223.","DOI":"10.1007\/s12551-017-0265-7"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43. Maatz H, Jens M, Liss M, Schafer S, Heinig M, Kirchner M, et al. RNA-binding protein RBM20 represses splicing to orchestrate cardiac pre-mRNA processing. <i>J Clin Invest<\/i> 2014; 124: 3419\u20133430.","DOI":"10.1172\/JCI74523"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44. Brauch KM, Karst ML, Herron KJ, de Andrade M, Pellikka PA, Rodeheffer RJ, et al. Mutations in ribonucleic acid binding protein gene cause familial dilated cardiomyopathy. <i>J Am Coll Cardiol<\/i> 2009; 54: 930\u2013941.","DOI":"10.1016\/j.jacc.2009.05.038"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45. Vang S, Corydon TJ, B\u00f8rglum AD, Scott MD, Frydman J, Mogensen J, et al. Actin mutations in hypertrophic and dilated cardiomyopathy cause inefficient protein folding and perturbed filament formation. <i>FEBS J<\/i> 2005; 272: 2037\u20132049.","DOI":"10.1111\/j.1742-4658.2005.04630.x"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46. Menon SC, Michels VV, Pellikka PA, Ballew JD, Karst ML, Herron KJ, et al. Cardiac troponin T mutation in familial cardiomyopathy with variable remodeling and restrictive physiology. <i>Clin Genet<\/i> 2008; 74: 445\u2013454.","DOI":"10.1111\/j.1399-0004.2008.01062.x"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47. Tran Vu MT, Nguyen TV, Van Huynh N, Nguyen Thai HT, Nguyen VP, Ho Huynh TD. Presence of hypertrophic cardiomyopathy related gene mutations and clinical manifestations in Vietnamese patients with hypertrophic cardiomyopathy. <i>Circ J<\/i> 2019; 83: 1908\u20131916.","DOI":"10.1253\/circj.CJ-19-0190"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48. Van Driest SL, Ellsworth EG, Ommen SR, Tajik AJ, Gersh BJ, Ackerman MJ. Prevalence and spectrum of thin filament mutations in an outpatient referral population with hypertrophic cardiomyopathy. <i>Circulation<\/i> 2003; 108: 445\u2013451.","DOI":"10.1161\/01.CIR.0000080896.52003.DF"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49. Richard P, Charron P, Carrier L, Ledeuil C, Cheav T, Pichereau C, et al. Hypertrophic cardiomyopathy: Distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy. <i>Circulation<\/i> 2003; 107: 2227\u20132232.","DOI":"10.1161\/01.CIR.0000066323.15244.54"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50. Schultheiss HP, Fairweather DL, Caforio ALP, Escher F, Hershberger RE, Lipshultz SE, et al. Dilated cardiomyopathy. <i>Nat Rev Dis Primers<\/i> 2019; 5: 32.","DOI":"10.1038\/s41572-019-0084-1"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51. Olson TM, Michels VV, Thibodeau SN, Tai YS, Keating MT. Actin mutations in dilated cardiomyopathy, a heritable form of heart failure. <i>Science<\/i> 1998; 280: 750\u2013752.","DOI":"10.1126\/science.280.5364.750"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52. Walsh R, Buchan R, Wilk A, John S, Felkin LE, Thomson KL, et al. Defining the genetic architecture of hypertrophic cardiomyopathy: Re-evaluating the role of non-sarcomeric genes. <i>Eur Heart J<\/i> 2017; 38: 3461\u20133468.","DOI":"10.1093\/eurheartj\/ehw603"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53. Milasin J, Muntoni F, Severini GM, Bartoloni L, Vatta M, Krajinovic M, et al. A point mutation in the 5\u2019 splice site of the dystrophin gene first intron responsible for X-linked dilated cardiomyopathy. <i>Hum Mol Genet<\/i> 1996; 5: 73\u201379.","DOI":"10.1093\/hmg\/5.1.73"},{"key":"54","doi-asserted-by":"crossref","unstructured":"54. Feng J, Yan J, Buzin CH, Towbin JA, Sommer SS. Mutations in the dystrophin gene are associated with sporadic dilated cardiomyopathy. <i>Mol Genet Metab<\/i> 2002; 77: 119\u2013126.","DOI":"10.1016\/S1096-7192(02)00153-1"},{"key":"55","doi-asserted-by":"crossref","unstructured":"55. Cho A, Seong MW, Lim BC, Lee HJ, Byeon JH, Kim SS, et al. Consecutive analysis of mutation spectrum in the dystrophin gene of 507 Korean boys with Duchenne\/Becker muscular dystrophy in a single center. <i>Muscle and Nerve<\/i> 2017; 55: 727\u2013734.","DOI":"10.1002\/mus.25396"},{"key":"56","doi-asserted-by":"crossref","unstructured":"56. Pugh TJ, Kelly MA, Gowrisankar S, Hynes E, Seidman MA, Baxter SM, et al. The landscape of genetic variation in dilated cardiomyopathy as surveyed by clinical DNA sequencing. <i>Genet Med<\/i> 2014; 16: 601\u2013608.","DOI":"10.1038\/gim.2013.204"},{"key":"57","doi-asserted-by":"crossref","unstructured":"57. L\u00e9vesque S, Auray-Blais C, Gravel E, Boutin M, Dempsey-Nunez L, Jacques PE, et al. Diagnosis of late-onset Pompe disease and other muscle disorders by next-generation sequencing. <i>Orphanet J Rare Dis<\/i> 2016; 11: 8.","DOI":"10.1186\/s13023-016-0390-6"},{"key":"58","doi-asserted-by":"crossref","unstructured":"58. Van Driest SL, Vasile VC, Ommen SR, Will ML, Tajik AJ, Gersh BJ, et al. Myosin binding protein C mutations and compound heterozygosity in hypertrophic cardiomyopathy. <i>J Am Coll Cardiol<\/i> 2004; 44: 1903\u20131910.","DOI":"10.1016\/j.jacc.2004.07.045"},{"key":"59","doi-asserted-by":"crossref","unstructured":"59. Tesson F, Richard P, Charron P, Mathieu B, Cruaud C, Carrier L, et al. Genotype-phenotype analysis in four families with mutations in \u03b2-myosin heavy chain gene responsible for familial hypertrophic cardiomyopathy. <i>Hum Mutat<\/i> 1998; 12: 385\u2013392.","DOI":"10.1002\/(SICI)1098-1004(1998)12:6<385::AID-HUMU4>3.0.CO;2-E"},{"key":"60","doi-asserted-by":"crossref","unstructured":"60. Minoche AE, Horvat C, Johnson R, Gayevskiy V, Morton SU, Drew AP, et al. Genome sequencing as a first-line genetic test in familial dilated cardiomyopathy. <i>Genet Med<\/i> 2019; 21: 650\u2013662.","DOI":"10.1038\/s41436-018-0084-7"},{"key":"61","doi-asserted-by":"crossref","unstructured":"61. Van der Zwaag PA, van Rijsingen IAW, Asimaki A, Jongbloed JDH, van Veldhuisen DJ, Wiesfeld ACP, et al. Phospholamban R14del mutation in patients diagnosed with dilated cardiomyopathy or arrhythmogenic right ventricular cardiomyopathy: Evidence supporting the concept of arrhythmogenic cardiomyopathy. <i>Eur J Heart Fail<\/i> 2012; 14: 1199\u20131207.","DOI":"10.1093\/eurjhf\/hfs119"},{"key":"62","doi-asserted-by":"crossref","unstructured":"62. Toledo RA, Burnichon N, Cascon A, Benn DE, Bayley JP, Welander J, et al. Consensus Statement on next-generation-sequencing-based diagnostic testing of hereditary phaeochromocytomas and paragangliomas. <i>Nat Rev Endocrinol<\/i> 2017; 13: 233\u2013247.","DOI":"10.1038\/nrendo.2016.185"},{"key":"63","doi-asserted-by":"crossref","unstructured":"63. Semplicini C, Vissing J, Dahlqvist JR, Stojkovic T, Bello L, Witting N, et al. Clinical and genetic spectrum in limb-girdle muscular dystrophy type 2E. <i>Neurology<\/i> 2015; 84: 1772\u20131781.","DOI":"10.1212\/WNL.0000000000001519"},{"key":"64","doi-asserted-by":"crossref","unstructured":"64. Hirtle-Lewis M, Desbiens K, Ruel I, Rudzicz N, Genest J, Engert JC, et al. The genetics of dilated cardiomyopathy: A prioritized candidate gene study of LMNA, TNNT2, TCAP, and PLN. <i>Clin Cardiol<\/i> 2013; 36: 628\u2013633.","DOI":"10.1002\/clc.22193"},{"key":"65","doi-asserted-by":"crossref","unstructured":"65. Kamisago M, Sharma SD, DePalma SR, Solomon S, Sharma P, McDonough B, et al. Mutations in sarcomere protein genes as a cause of dilated cardiomyopathy. <i>N Engl J Med<\/i> 2000; 343: 1688\u20131696.","DOI":"10.1056\/NEJM200012073432304"},{"key":"66","doi-asserted-by":"crossref","unstructured":"66. Van Acker H, De Sutter J, Vandekerckhove K, De Ravel TJ, Verhaaren H, De Backer J. Dilated cardiomyopathy caused by a novel TNNT2 mutation-Added value of genetic testing in the correct identification of affected subjects. <i>Int J Cardiol<\/i> 2010; 144: 307\u2013309.","DOI":"10.1016\/j.ijcard.2009.03.003"},{"key":"67","doi-asserted-by":"crossref","unstructured":"67. Lakdawala NK, Funke BH, Baxter S, Cirino AL, Roberts AE, Judge DP, et al. Genetic testing for dilated cardiomyopathy in clinical practice. <i>J Card Fail<\/i> 2012; 18: 296\u2013303.","DOI":"10.1016\/j.cardfail.2012.01.013"},{"key":"68","doi-asserted-by":"crossref","unstructured":"68. Fernlund E, \u00d6sterberg AW, Kuchinskaya E, Gustafsson M, Jansson K, Gunnarsson C. Novel genetic variants in BAG3 and TNNT2 in a Swedish family with a history of dilated cardiomyopathy and sudden cardiac death. <i>Pediatr Cardiol<\/i> 2017; 38: 1262\u20131268.","DOI":"10.1007\/s00246-017-1655-0"},{"key":"69","doi-asserted-by":"crossref","unstructured":"69. Cecconi M, Parodi MI, Formisano F, Spirito P, Autore C, Musumeci MB, et al. Targeted next-generation sequencing helps to decipher the genetic and phenotypic heterogeneity of hypertrophic cardiomyopathy. <i>Int J Mol Med<\/i> 2016; 38: 1111\u20131124.","DOI":"10.3892\/ijmm.2016.2732"},{"key":"70","doi-asserted-by":"crossref","unstructured":"70. Dorsch LM, Kuster DWD, Jongbloed JDH, Boven LG, van Spaendonck-Zwarts KY, Suurmeijer AJH, et al. The effect of tropomyosin variants on cardiomyocyte function and structure that underlie different clinical cardiomyopathy phenotypes. <i>Int J Cardiol<\/i> 2021; 323: 251\u2013258.","DOI":"10.1016\/j.ijcard.2020.08.101"},{"key":"71","doi-asserted-by":"crossref","unstructured":"71. Herman DS, Lam L, Taylor MRG, Wang L, Teekakirikul P, Christodoulou D, et al. Truncations of titin causing dilated cardiomyopathy. <i>N Engl J Med<\/i> 2012; 366: 619\u2013628.","DOI":"10.1056\/NEJMoa1110186"}],"container-title":["Circulation Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/85\/9\/85_CJ-21-0077\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T04:25:57Z","timestamp":1715142357000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/85\/9\/85_CJ-21-0077\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,25]]},"references-count":71,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1253\/circj.cj-21-0077","relation":{},"ISSN":["1346-9843","1347-4820"],"issn-type":[{"value":"1346-9843","type":"print"},{"value":"1347-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,25]]},"article-number":"CJ-21-0077"}}